What Is Beta Thalassemia? The Basics

Beta thalassemia is a blood disorder passed down through families that affects how your body makes hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen to every part of your body. When you have beta thalassemia, your body makes less hemoglobin and fewer healthy red blood cells than normal. This leads to a condition called anemia, which can range from very mild to severe depending on the type you have.

What Causes Beta Thalassemia?

Beta thalassemia is caused by changes, called mutations, in the beta-globin gene. This gene gives the instructions for making one part of hemoglobin. You inherit two copies of this gene — one from each parent.

If you inherit one mutated gene, you have a mild form called beta thalassemia minor or trait. If you inherit two mutated genes, you have a more serious form called beta thalassemia major or intermedia. The severity depends on the specific mutations involved.

These mutations are most common in people of Mediterranean, Middle Eastern, South Asian, and Southeast Asian ancestry. Current research suggests that about 1.5 percent of the global population carries a beta thalassemia mutation. The trait itself does not cause illness, but it can pass the condition to children.

What Are the Different Types of Beta Thalassemia?

The three main types are based on how many genes are affected and how severe the anemia is. Understanding your type is the most important step in knowing what to expect.

People with beta thalassemia minor usually have no symptoms and may not even know they have it. A routine blood test might show small red blood cells, but this is often mistaken for iron deficiency. People with beta thalassemia major usually show symptoms within the first two years of life.

What Are the Symptoms of Beta Thalassemia?

Symptoms depend entirely on which type you have. For beta thalassemia minor, there are often no symptoms at all. Some people report feeling slightly more tired than usual, but this is not consistent.

For beta thalassemia intermedia, symptoms can include:

• Moderate to severe anemia
• Slow growth and delayed puberty in children
• Bone changes, especially in the face and skull
• An enlarged spleen

For beta thalassemia major, symptoms are serious and appear early in life. Babies may have pale skin, poor feeding, and failure to thrive. Without treatment, the body tries to make more red blood cells in the bone marrow, but these cells are fragile and die quickly. This overwork causes bones to widen and become misshapen. The spleen and liver can also enlarge as they work to filter out damaged red blood cells.

One non-obvious point: people with beta thalassemia minor are sometimes misdiagnosed with iron deficiency anemia. Taking iron supplements when you do not need them can cause iron overload, which is harmful. A simple blood test called hemoglobin electrophoresis can tell the difference.

How Is Beta Thalassemia Diagnosed?

Diagnosis usually starts with a complete blood count, or CBC. This test measures the number and size of your red blood cells. In beta thalassemia, red blood cells are often smaller than normal, a condition called microcytosis.

If the CBC suggests thalassemia, the next step is hemoglobin electrophoresis. This test separates the different types of hemoglobin in your blood. People with beta thalassemia have higher levels of hemoglobin A2 and sometimes hemoglobin F, which is the fetal form of hemoglobin.

Genetic testing can identify the exact mutation. This is especially useful for family planning or for confirming a diagnosis in someone with intermedia or major. Prenatal testing is also available for couples who know they are carriers.

What Are the Treatment Options for Beta Thalassemia?

Treatment depends on the severity. For beta thalassemia minor, no treatment is needed. The condition does not affect lifespan or quality of life.

For beta thalassemia intermedia, treatment may include:

• Regular blood transfusions during growth spurts or pregnancy
• Folic acid supplements to support red blood cell production
• Splenectomy, or removal of the spleen, if it becomes too enlarged

For beta thalassemia major, treatment is lifelong and intensive. Regular blood transfusions are needed every two to four weeks to keep hemoglobin levels high enough for normal growth and activity. These transfusions save lives, but they come with a serious side effect: iron overload. The body cannot easily get rid of the extra iron from transfused blood, so it builds up in the heart, liver, and endocrine glands.

To manage iron overload, patients take chelation therapy. This is medication that binds to excess iron so the body can excrete it. Chelation can be given as an injection, a pill, or an infusion. Without it, iron overload causes organ damage and early death.

Bone marrow transplant is the only cure for beta thalassemia major as of 2026. It replaces the faulty stem cells with healthy ones from a matched donor. This is a high-risk procedure with serious potential complications, including graft-versus-host disease and infection. It is not an option for everyone. Gene therapy is an emerging area of research, and some patients have been treated successfully in clinical trials, but it is not yet widely available.

What Are Common Misconceptions About Beta Thalassemia?

A common myth is that beta thalassemia is contagious. It is not. It is a genetic condition that you are born with. You cannot catch it from someone else, and you cannot give it to someone through contact.

Another misconception is that people with beta thalassemia minor should avoid exercise or physical activity. This is not true. Most people with the trait have no limitations and can live completely normally. Only those with moderate or severe anemia need to adjust their activity levels based on how they feel.

Some people also believe that iron supplements help all types of anemia. This is false. People with beta thalassemia do not have low iron. Their problem is low hemoglobin production. Iron supplements can actually cause harm by adding to the body’s iron stores, especially in people who receive regular transfusions.